Who is selling Cambrex?

The British private equity firm Permira is selling its contract drugmaker Cambrex.

What is the targeted valuation for Cambrex?

Permira is targeting a valuation of as much as $4 billion for Cambrex.

Which publication reported on the Cambrex sale?

The Financial Times reported on the sale of Cambrex by Permira.

Editorial & Advertiser disclosure

Global Banking & Finance Review® is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

Home > Finance > Permira seeks $4 billion for sale of contract drugmaker Cambrex, FT reports

Finance

Permira seeks $4 billion for sale of contract drugmaker Cambrex, FT reports

Published by Global Banking & Finance Review®

Posted on September 6, 2025

1 min read

Last updated: January 22, 2026

Founders of The Entertainer toy chain hand over control to workers - Global Banking & Finance Review — Image depicting the founders of The Entertainer, Gary and Catherine Grant, announcing the transition of their toy retailer to employee ownership, emphasizing the significance of this move in the finance sector.

Permira seeks $4 billion for sale of contract drugmaker Cambrex, FT reports

Quick Summary

Permira seeks $4 billion for sale of contract drugmaker Cambrex, FT reports

Key Takeaways

Frequently Asked Questions about Permira seeks $4 billion for sale of contract drugmaker Cambrex, FT reports